Sep 2026· Frontiers in Cell and Developmental Biology· Vol 14· 0 citations· 159 references
Medicine
TL;DR
The therapeutic potential of targeting MAMs structure and function as a strategy to restore organelle homeostasis and improve cardiovascular outcomes is highlighted.
Abstract
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are dynamic contact sites that coordinate structural and functional communication between the endoplasmic reticulum (ER) and mitochondria. By organizing tethering complexes, calcium channels, lipid-transfer machinery, and stress-responsive signaling modules, MAMs regulate Ca2+ homeostasis, lipid metabolism, mitochondrial dynamics, mitophagy, oxidative stress, endoplasmic reticulum stress, and cell fate determination. Increasing evidence indicates that MAMs dysfunction is critically involved in the initiation and progression of cardiovascular diseases (CVDs), including atherosclerosis, pulmonary hypertension, myocardial ischemia/reperfusion injury, myocardial infarction, diabetic cardiomyopathy, dilated cardiomyopathy, and heart failure. In these settings, disrupted or excessive ER-mitochondria coupling can trigger mitochondrial Ca2+ overload, metabolic remodeling, reactive oxygen species accumulation, inflammatory activation, and programmed cell death. Conversely, preserved or appropriately remodeled MAMs integrity supports mitochondrial bioenergetics, adaptive stress responses, and cardiomyocyte or vascular cell survival. This review summarizes the molecular architecture and biological functions of major MAMs-associated complexes, and discusses their context-dependent roles in cardiovascular pathophysiology. We further highlight the therapeutic potential of targeting MAMs structure and function as a strategy to restore organelle homeostasis and improve cardiovascular outcomes.
A novel clinical strategy is proposed: targeting MAMs through a multi-level framework of "structural stabilization-calcium modulation-mitophagy restoration," delivered during perioperative windows such as organ preservation and machine perfusion, elevating MAMs from a mechanistic concept to a monitorable, stratifiable,...
Luo He, Ting Yang, Zhengda Lou et al.· Tissue & Cell· 0 citations
This review contrasts rodent and human data, where MAM composition and glucotoxic responses diverge, and considers therapeutic strategies, such as incretin-based agents and the mitochondrial-derived peptide MOTS-c, that target this interface to preserve β-cell function in diabetes.
S. Niinuma, A. S. Takemoto, William Junior Khalil et al.· Cells· 0 citations
This Review positions mito-ER-LD contact sites not simply as structural interfaces, but as core nodes that regulate lipid metabolic reprogramming in T2DM, thereby providing a mechanistic framework for targeting organelle crosstalk in metabolic disease.
Xin-Yi Fang, Jia-Qi Gao, Yan Wang et al.· Journal of Lipid Research· 0 citations
Evidence suggesting that MAM dysregulation may contribute to the abnormal metabolism of phospholipids, ceramides, cholesterol, fatty acids, and triglycerides in renal cells is examined, thereby addressing a gap between previous reviews on renal lipotoxicity and those focusing on MAM-dependent calcium signaling in kidne...
Yi-Le Gao, Ming-Hui Shao, Ya Fang et al.· Bioscience Reports· 0 citations
This review discusses the biochemical links between oxidative stress and mitochondrial dysfunction and their roles in cardiovascular disease, type 2 diabetes, neurodegeneration, metabolic liver disease, cancer, and aging, and widely used biomarkers and current therapeutic strategies.
A. Abdulkader, A. M. Hussein· World Journal of Chemical an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.